Kathleen Laporte - Nov 1, 2021 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte
Stock symbol
ETNB
Transactions as of
Nov 1, 2021
Transactions value $
$0
Form type
4
Date filed
11/3/2021, 04:36 PM
Previous filing
Oct 12, 2021
Next filing
Jan 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +25K $0.00 25K Nov 1, 2021 Common Stock 25K $18.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in equal installments on November 1, 2022, November 1, 2023 and November 1, 2024, subject to the Reporting Person's continued service to the Issuer through each vesting date.